High density lipoprotein is an inappropriate substrate for hepatic lipase in postmenopausal women

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 142-145

  Zago, Valeria ^a   Miksztowicz, Verónica ^a   Cacciagiú, Leonardo ^a   Basilio, Francisco ^a   Berg, Gabriela ^a   Schreier, Laura ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

HDL functionality; Hepatic lipase; High density lipoprotein; Kinetics; Postmenopause

Indexed keywords

FATTY ACID; HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL; HEPATIC LIPASE, HUMAN; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME SUBSTRATE; EX VIVO STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; BLOOD; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MIDDLE AGED;

ADULT; FEMALE; HUMANS; KINETICS; LIPASE; LIPOPROTEINS, HDL; MIDDLE AGED; POSTMENOPAUSE; TRIGLYCERIDES;

EID: 84866498773     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.08.026     Document Type: Article

References (27)

1. Gordon, T., Castelli, W.P., Hjortland, M.C., et al. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62 (1977), 707–714.
2. Sviridov, D., Mukhamedova, N., Remaley, A.T., et al. Antiatherogenic functionality of high density lipoprotein: how much versus how good. J Atheroscler Thromb 15 (2008), 52–62.
3. Barter, P.J., Rye, K.A., Relationship between the concentration and antiatherogenic activity of high-density lipoproteins. Curr Opin Lipidol 17 (2006), 399–403.
4. Lewis, G.F., Rader, D.J., New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005), 1221–1232.
5. Rosenson, R.S., Brewer, H.B. Jr., Davidson, W.S., et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 25 (2012), 11905–11919.
6. Berg, G., Siseles, N., Gonzalez, A.I., et al. Higher values of Hepatic Lipase Activity in post menopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause 8 (2001), 51–57.
7. Matthews, K.A., Kuller, L.H., Sutton-Tyrrell, K., et al. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 32 (2001), 1104–1111.
8. Zago, V., Sanguinetti, S., Brites, F., et al. Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women. Atherosclerosis 177 (2004), 203–210.
9. 2. Clin Chem 29 (1983), 2026–2030.
10. Assman, G., Jabs, H., Kohnert, U., et al. LDL (low density lipoprotein) cholesterol determination in blood serum following precipitation of LDL with poly(vinyl sulphate). Clin Chim Acta 140 (1984), 77–83.
11. Schumaker, V., Puppione, D., Sequential flotation ultracentrifugation. Segrest, J., Albers, J., (eds.) Methods in enzimology, 128, 1986, Academic Press, London—UK, 155–170.
12. Noble, R.P., Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 9 (1968), 693–700.
13. Barlett, G.R., Phosphorus assay in column chromatography. J Biol Chem 234 (1959), 466–468.
14. Lowry, O., Rosebrough, N., Farr, A., et al. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951), 265–275.
15. Hedrick, C.C., Castellani, L.W., Wong, H., et al. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions. J Lipid Res 42 (2001), 563–570.
16. Rashid, S., Barrett, P.H., Uffelman, K.D., et al. Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation. Arterioscler Thromb Vasc Biol 22 (2002), 483–487.
17. Hime, N.J., Barter, P.J., Rye, K.A., The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol. J Biol Chem 273 (1998), 27191–27198.
18. Muzzio, M.L., Berg, G., Zago, V., et al. Circulating small dense LDL, endothelial injuring factors and fibronectin in healthy postmenopausal women. Clin Chim Acta 381 (2007), 57–63.
19. Tilly-Kiesi, M., Schaefer, E.J., Knudsen, P., et al. Lipoprotein metabolism in subjects with hepatic lipase deficiency. Metabolism 53 (2004), 520–525.
20. Brown, R.J., Lagor, W.R., Sankaranaravanan, S., et al. Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins. Circ Res 107 (2010), 357–364.
21. Tall, A.R., Plasma cholesteryl ester transfer protein. J Lipid Res 34 (1993), 1255–1274.
22. Greaves, K.A., Going, S.B., Fernandez, M.L., et al. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in Hispanic and Anglo postmenopausal women: associations with total and regional body fat. Metabolism 52 (2003), 282–289.
23. Skeggs, J.W., Morton, R.E., LDL and HDL enriched in triglyceride promote abnormal cholesterol transport. J Lipid Res 43 (2001), 1264–1274.
24. Greene, D.J., Skeggs, J.W., Morton, R.E., Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI). J Biol Chem 266 (2001), 4804–4811.
25. Rashid, S., Trinh, D.K., Uffelman, K.D., et al. Expression of human hepatic lipase in the rabbit model preferentially enhances the clearance of triglyceride-enriched versus native high-density lipoprotein apolipoprotein A-I. Circulation 107 (2003), 3066–3072.
26. Rosenson, R.S., Brewer, H.B. Jr., Chapman, M.J., et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem 57 (2011), 392–410.
27. Weng, W., Brandenburg, N.A., Zhong, S., et al. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies in apoA-II and hepatic lipase double knockout mice. J Lipid Res 40 (1999), 1064–1070.